openPR Logo

Press Releases from Epidermolysis Bullosa (EB) Therapeutics- Pharma Proff (1 total)

Epidermolysis Bullosa (EB) Therapeutics- Pipeline Analysis 2018 | Abeona Therape …

Epidermolysis bullosa (EB), is a rare genetic connective tissue skin disorder that causes blisters and allows skin to become fragile. Blisters and areas of skin loss (erosions) occur in response to minor injury or friction, such as rubbing or scratching. The disease affects 1 out of every 20,000 births in the U.S. Download the sample report @ https://www.pharmaproff.com/request-sample/1130 The symptoms of epidermolysis bullosa are redness and heat around an open area

Go To Page:   1 2 3 4 5 6 7 8 9 10